The efficacy of current prognostic models in predicting outcome of patients with myelodysplastic syndromes at the time of hypomethylating agent failure

• Aziz Nazha,
• Rami S. Komrokji,
• Guillermo Garcia-Manero,
• John Barnard,
• Gail J. Roboz,
• David P. Steensma,
• Amy E. DeZern,
• Katrina Zell,
• Cassie Zimmerman,
• Najla Al Ali,
• Elias Jabbour,
• Molly D. Greenberg,
• Hagop M. Kantarjian,
• Jaroslaw P. Maciejewski,
• Alan F. List,
• Mikkael A. Sekeres

Affiliations

Aziz Nazha

Leukemia Program and Department of Translational Hematology and Oncology Research, Cleveland Clinic, OH, USA

Rami S. Komrokji

Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA

Guillermo Garcia-Manero

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

John Barnard

Department of Quantitative Health Sciences, Cleveland Clinic, OH, USA

Gail J. Roboz

Division of Hematology and Oncology, New York Presbyterian Hospital-Weill Cornell Medical College, NY, USA

David P. Steensma

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Amy E. DeZern

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA

Katrina Zell

Department of Quantitative Health Sciences, Cleveland Clinic, OH, USA

Cassie Zimmerman

Leukemia Program and Department of Translational Hematology and Oncology Research, Cleveland Clinic, OH, USA

Najla Al Ali

Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA

Elias Jabbour

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Molly D. Greenberg

Division of Hematology and Oncology, New York Presbyterian Hospital-Weill Cornell Medical College, NY, USA

Hagop M. Kantarjian

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Jaroslaw P. Maciejewski

Leukemia Program and Department of Translational Hematology and Oncology Research, Cleveland Clinic, OH, USA

Alan F. List

Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA

Mikkael A. Sekeres

Leukemia Program and Department of Translational Hematology and Oncology Research, Cleveland Clinic, OH, USA